Clinical trial for Chronic Kidney Disease(CKD)
Official title Implementation pRogram to Improve Screening and Management for CKD in Diabetes (Program 1) (IRIS-CKD)
ClinicalTrials.gov ID: NCT06906627
What this study is testing
- What it's testing
- The study aims to see if the program helps doctors follow guidelines for checking kidney health in people with type 2 diabetes.
- Who it's for
- Adults with type 2 diabetes who have chronic kidney disease.
- What's involved
- Participants will use the program, which includes tools and training for doctors, and may involve regular kidney tests.
- Time commitment
- The study lasts until the program is fully implemented; participants will have routine visits as part of their care.
- Time commitment: about 15 months
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Screening Program-
- Adults with type 2 diabetes (T2D)
- Receiving primary care within the healthcare system, Primary Care Provider (PCP) visit within the past 24 months (any PCP provider, including APP).
- Lack of estimated glomerular filtration rate (eGFR) and/or urine albumin- creatinine ratio (UACR) measurement in the prior 15 months within the EHR
You likely can't join if
- Chronic kidney disease (CKD) diagnosis
The study team makes the final eligibility decision.
Where it is enrolling
- Birmingham, Alabama, United States
- St. Petersburg, Florida, United States
- Ann Arbor, Michigan, United States
- Duluth, Minnesota, United States
- Durham, North Carolina, United States
- Houston, North Carolina, United States
- Temple, Texas, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The study runs about 15 months per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Birmingham, Alabama, United States; St. Petersburg, Florida, United States; Ann Arbor, Michigan, United States; Duluth, Minnesota, United States; Durham, North Carolina, United States; Houston, North Carolina, United States and 1 more location. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.